GEHC
What one share of Ge Healthcare Technologies holds
X – Ray Apparatus and Tubes and Related Irradiation Apparatus
GE HealthCare Technologies Inc. (“GE HealthCare,” the “Company,” “our,” “us,” or “we”) is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases.
Ge Healthcare Technologies’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-03-31; the balance sheet is as of 2026-03-31.
| Sales | $45.86 |
|---|---|
| Profit | $4.17 |
| Capex (buildings and equipment) | $1.11 |
| Free cash flow | $3.32 |
| Dividends | $0.14 |
| Cash and investments | $4.97 |
| Debt | $22.37 |
| Book value | $23.45 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | $38.73 | $4.95 | $0.55 | $2.99 | — | $36.73 |
| 2022 | $40.40 | $4.22 | $0.68 | $4.02 | — | $20.61 |
| 2023 | $42.69 | $3.02 | $0.84 | $3.74 | $0.12 | $15.67 |
| 2024 | $42.86 | $4.34 | $0.87 | $3.39 | $0.12 | $18.47 |
| 2025 | $45.03 | $4.55 | $1.05 | $3.29 | $0.14 | $22.77 |